Company intelligence / Profile preview

Biopharmed

Ownership: Private
Development stage: Other

Overview

Biopharmed for Pharmaceutical Industries is an Egyptian pharmaceutical company focused on the manufacturing and distribution of generic medicines and health supplements. Founded in 2016 and headquartered in Cairo, the company operates a manufacturing facility in Badr City designed to meet international quality standards. Its product portfolio includes a range of therapeutic solutions for gastrointestinal, respiratory, and infectious diseases, as well as a variety of nutritional supplements. Biopharmed aims to provide high-quality, affordable healthcare products to the Egyptian market and the broader MENA region.

Therapeutic areas: Infectious DiseasesPulmonologyGastroenterologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Biopharmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biopharmed.